FDA Grants 510(k) Clearance to Morpheus8 for Soft Tissue Contraction
The U.S. Food and Drug Administration (FDA) has cleared InMode’s Morpheus8 Applicators for the delivery of fractional radiofrequency use in dermatologic skin procedures where coagulation/contraction of soft tissue or hemostasis is needed. Coinciding with this clearance is the launch of the new IgniteRF and OptimasMAX platforms, which include the Morpheus8 family of handpieces. The modular […]